Cephalon submits Treanda NDA

CEPH submitted an NDA to FDA for Treanda bendamustine to treat chronic lymphocytic leukemia (CLL). Treanda has Orphan Drug designation for the indication from FDA. CEPH has U.S. rights to the alkylati...